(RTTNews) - Bio-Techne (TECH), a life science company, on Friday announced the launch of a new line of AI-engineered designer proteins aimed at advancing cell therapy and regenerative medicine. The ...
--Bio-Techne Corporation, a global provider of cutting-edge life science tools, today announced an Early Access Program for its latest advancement in spatial biology: a powerful new assay for in situ ...
MINNEAPOLIS, Jan. 10, 2025 /PRNewswire/ -- Bio-Techne (TECH), a global leader in life science tools and reagents, today announced the launch of new designer proteins engineered using advanced ...
MINNEAPOLIS, Dec. 9, 2025 /PRNewswire/ -- Bio-Techne Corporation, a global provider of life science tools, reagents, and diagnostic products, today announced the expanded launch and first shipment of ...
Bio-Techne Corporation, a global provider of life science research tools, analytical instruments, and diagnostics, today ...
Bio-Techne’s TECH GMP reagents, including GMP proteins and small molecules, remain a cornerstone of its cell therapy offering. Acquisitions have continued to play an important role in the company’s ...
May 7 (Reuters) - Bio-Techne (TECH.O), opens new tab on Wednesday beat Wall Street estimates for third-quarter profit, driven by growth in its unit that provides proteins, antibodies and other ...
AI is accelerating protein design by enhancing structure prediction, candidate screening, and downstream analysis, enabling faster and more consistent results. Automation complements these advances by ...
Combines chemiluminescence detection with dual-channel fluorescence in the near-infrared and infrared (NIR and IR) ranges for expanded multiplexing Enables up to 24 targets per sample and supports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results